Jak2 mutation expands the thrombophilic panel in children
- PMID: 32654426
- DOI: 10.1111/jth.14999
Jak2 mutation expands the thrombophilic panel in children
Abstract
Cerebral sinus venous thrombosis (CSVT) is an important cause of vascular accidents in children. The diagnosis of the underlying disease allows appropriate and timely management of the risk factors and guide therapy, but the etiology remains unknown in 20% to 25% of the cases. We present the first case of a child presenting with CSVT caused by the Janus Kinase 2 (JAK2) V617F mutation, occurring without the hematological abnormalities diagnostic for myeloproliferative neoplasms. We therefore suggest including the molecular study of the JAK2 gene in the coagulation panel of all children affected by CSVT of unknown cause.
Keywords: coagulation; myeloproliferative neoplasms; pediatric; thrombophilia; venous sinus thrombosis.
© 2020 International Society on Thrombosis and Haemostasis.
References
REFERENCES
-
- deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345(6):417-423.
-
- Dsouza S, Aylward BS, Rogers DL, Aylward SC. Presenting symptomatology and risk factors in pediatric secondary intracranial hypertension due to venous sinus thrombosis. Pediatr Neurol. 2019;101:53-56.
-
- Javed I, Sultan T, Rehman ZU, Yaseen MR. Clinical spectrum and outcome of cerebral venous sinus thrombosis in children. J Coll Physicians Surg Pak. 2018;28(5):390-393.
-
- Ichord RN, Benedict SL, Chan AK, Kirkham FJ. Nowak-Göttl U, International Paediatric Stroke Study Group. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child. 2015;100(2):174-179.
-
- Lamy M, Palazzo P, Agius P, et al. Should we screen for Janus kinase 2 V617F mutation in cerebral venous thrombosis? Cerebrovasc Dis. 2017;44(3-4):97-104.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous